Australian Pharmaceutical Industries
Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2006
Unaccounted profit after IT-system implementation
After a new IT system was implemented, API identified A$17.2 million of declared profit that could not be traced. Forensic accountants did not locate the amount, and the company wrote it off, producing a net loss of A$17.2 million. The episode also contributed to the departure of chief executive Jeff Sher after a disagreement with the board about the treatment of the discrepancy.
2005
Priceline employment dispute under WorkChoices
Priceline dismissed 32 workers for stated operational reasons during the period of the WorkChoices industrial-relations legislation. A dismissed store-layout planner challenged his termination and alleged that his position had been replaced with a lower-paid role. The Australian Industrial Relations Commission found in Priceline’s favour, concluding that the dismissal resulted from financial difficulties and structural reorganisation.